Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
Rolf P Kreutz,1,2 Jeffrey A Breall,1 Anjan Sinha,1 Elisabeth von der Lohe,1 Richard J Kovacs,1 David A Flockhart,2,† 1Krannert Institute of Cardiology, 2Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA †David A Flockhart passed aw...
Guardado en:
Autores principales: | Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65db2ed8857346b4a69976f42d79a6b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala FS, et al.
Publicado: (2020) -
Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
por: Ching Wei Russell Chen, et al.
Publicado: (2019) -
Clopidogrel-Induced Interstitial Lung Disease: A Case Report
por: An J, et al.
Publicado: (2021) -
Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
por: Jun Xu, et al.
Publicado: (2019) -
Clinical investigation of transradial access for emergent percutaneous coronary intervention in patients with acute myocardial infarction
por: Qin X, et al.
Publicado: (2013)